Back to Agenda
Security the Chain: US Legislative Reforms, Regulatory Actions, and Recommendations to Mitigate Drug Shortages
Session Chair(s)
Demetra Macheras, MBA
Director, Regulatory Policy and Intelligence - Regulatory Affairs
AbbVie, United States
There have been many legislative and regulatory efforts in the US to address drug shortages and address assurance of supply. This session will provide an overview of these legislative and regulatory actions and provide recommendations to support drug shortage mitigation and supply chain transparency. This session will also demonstrate why addressing the issue of drug shortages is so critical, by addressing the impact of drug shortages from the patient perspective.
Learning Objective : Define various US legislative and regulatory actions to address drug shortages and understand their impact on assurance of supply and supply chain transparency; Understand the direct impact of drug shortages to the patient; Discuss themes and industry recommendations to address drug shortage prevention.
Speaker(s)
Patient Perspective
Laura Bray, MBA
Angels for Change, United States
Founder and Chief Change Maker
Evidence-Based Policy Reforms to Reduce Drug Shortages Today and Into the Future
Tony Lakavage, JD
USP, United States
Senior Vice President, Global External Affairs
ISPE Drug Shortages Initiative: Where We Have Been and Where We Are Going
Demetra Macheras, MBA
AbbVie, United States
Director, Regulatory Policy and Intelligence - Regulatory Affairs
Have an account?